Adrián Martín-Gutiérrez, -None-

Hospital Universitario Marques de Valdecilla, IDIVAL
Renedo de Piélagos, Spain

.

Presentation(s):

• 0200: Severe infections and malignancies in patients with cranial and extracranial giant cell arteritis treated with tocilizumab. National multicenter study of 471 patients of clinical practice

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 1613: Switching From Reference Tocilizumab to Biosimilar in Giant Cell Arteritis: Effectiveness and Safety in a Multicenter Study of 38 Patients

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 1612: Window of opportunity with tocilizumab therapy in giant cell arteritis. Multicenter study of 471 patients of clinical practice

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2610: Imaging remission in aortitis associated with giant cell arteritis. Multicenter study with tocilizumab in monotherapy and combined therapy

  Tuesday, October 28, 2025
  3:15 PM - 3:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose